Table: Phoenixbio - 6-MTH group results

PhoenixBio

14/11/2025 06:40

Nov 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            756 mln             788 mln           1.64     
                 (-4.0 pct)          (-10.6 pct)      (+6.4 pct)  
  Operating         5 mln            loss 98 mln        109 mln   
  Recurring        16 mln           loss 123 mln        116 mln   
  Net              12 mln           loss 124 mln        110 mln   
  EPS             3.03 yen         loss 30.89 yen      27.13 yen  
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T